News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
719,280 Results
Type
Article (44769)
Company Profile (327)
Press Release (674184)
Multimedia
Podcasts (84)
Webinars (12)
Section
Business (208216)
Career Advice (2061)
Deals (35974)
Drug Delivery (110)
Drug Development (84051)
Employer Resources (176)
FDA (16716)
Job Trends (15157)
News (353171)
Policy (33366)
Tag
Academia (2698)
Academic (1)
Accelerated approval (6)
Adcomms (26)
Allergies (89)
Alliances (50875)
ALS (98)
Alzheimer's disease (1448)
Antibody-drug conjugate (ADC) (152)
Approvals (16684)
Artificial intelligence (278)
Autoimmune disease (27)
Automation (16)
Bankruptcy (365)
Best Places to Work (11878)
BIOSECURE Act (22)
Biosimilars (111)
Biotechnology (235)
Bladder cancer (85)
Brain cancer (31)
Breast cancer (308)
Cancer (2433)
Cardiovascular disease (197)
Career advice (1722)
Career pathing (30)
CAR-T (176)
Cell therapy (492)
Cervical cancer (21)
Clinical research (68301)
Collaboration (916)
Company closure (2)
Compensation (575)
Complete response letters (27)
COVID-19 (2681)
CRISPR (49)
C-suite (264)
Cystic fibrosis (108)
Data (2338)
Decentralized trials (2)
Denatured (24)
Depression (51)
Diabetes (291)
Diagnostics (6521)
Digital health (19)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (127)
Drug pricing (111)
Drug shortages (30)
Duchenne muscular dystrophy (103)
Earnings (87949)
Editorial (44)
Employer branding (21)
Employer resources (150)
Events (115865)
Executive appointments (759)
FDA (18104)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (802)
Gene editing (122)
Generative AI (22)
Gene therapy (362)
GLP-1 (789)
Government (4567)
Grass and pollen (4)
Guidances (150)
Healthcare (19382)
Huntington's disease (25)
IgA nephropathy (27)
Immunology and inflammation (138)
Indications (30)
Infectious disease (2828)
Inflammatory bowel disease (152)
Inflation Reduction Act (8)
Influenza (52)
Intellectual property (100)
Interviews (324)
IPO (16769)
IRA (42)
Job creations (3705)
Job search strategy (1458)
Kidney cancer (11)
Labor market (43)
Layoffs (510)
Leadership (18)
Legal (8036)
Liver cancer (79)
Lung cancer (342)
Lymphoma (161)
Machine learning (9)
Management (59)
Manufacturing (342)
MASH (78)
Medical device (13657)
Medtech (13662)
Mergers & acquisitions (19782)
Metabolic disorders (759)
Multiple sclerosis (83)
NASH (18)
Neurodegenerative disease (108)
Neuropsychiatric disorders (32)
Neuroscience (2030)
NextGen: Class of 2025 (6744)
Non-profit (4624)
Now hiring (40)
Obesity (404)
Opinion (222)
Ovarian cancer (82)
Pain (101)
Pancreatic cancer (89)
Parkinson's disease (159)
Partnered (21)
Patents (249)
Patient recruitment (118)
Peanut (48)
People (58525)
Pharmaceutical (76)
Pharmacy benefit managers (19)
Phase I (21317)
Phase II (30040)
Phase III (22420)
Pipeline (1380)
Policy (158)
Postmarket research (2721)
Preclinical (9096)
Press Release (69)
Prostate cancer (114)
Psychedelics (38)
Radiopharmaceuticals (263)
Rare diseases (422)
Real estate (6027)
Recruiting (68)
Regulatory (22991)
Reports (47)
Research institute (2445)
Resumes & cover letters (358)
Rett syndrome (5)
RNA editing (5)
RSV (43)
Schizophrenia (76)
Series A (139)
Series B (92)
Service/supplier (12)
Sickle cell disease (58)
Special edition (19)
Spinal muscular atrophy (155)
Sponsored (30)
Startups (3719)
State (2)
Stomach cancer (16)
Supply chain (69)
Tariffs (49)
The Weekly (58)
Vaccines (733)
Venture capitalists (42)
Weight loss (272)
Women's health (38)
Worklife (17)
Date
Today (33)
Last 7 days (955)
Last 30 days (3101)
Last 365 days (33452)
2025 (12078)
2024 (36334)
2023 (41108)
2022 (52344)
2021 (56882)
2020 (55204)
2019 (47756)
2018 (36065)
2017 (33086)
2016 (32516)
2015 (38537)
2014 (32229)
2013 (27244)
2012 (29438)
2011 (30147)
2010 (28268)
Location
Africa (751)
Alabama (54)
Alaska (7)
Arizona (241)
Arkansas (14)
Asia (39364)
Australia (6528)
California (6488)
Canada (2078)
China (561)
Colorado (279)
Connecticut (286)
Delaware (158)
Europe (86743)
Florida (969)
Georgia (221)
Idaho (58)
Illinois (562)
India (26)
Indiana (326)
Iowa (11)
Japan (176)
Kansas (109)
Kentucky (25)
Louisiana (11)
Maine (62)
Maryland (935)
Massachusetts (4904)
Michigan (224)
Minnesota (407)
Mississippi (2)
Missouri (89)
Montana (28)
Nebraska (25)
Nevada (67)
New Hampshire (68)
New Jersey (1816)
New Mexico (30)
New York (1833)
North Carolina (1058)
North Dakota (9)
Northern California (2837)
Ohio (212)
Oklahoma (15)
Oregon (35)
Pennsylvania (1443)
Puerto Rico (13)
Rhode Island (33)
South America (1127)
South Carolina (25)
South Dakota (1)
Southern California (2426)
Tennessee (107)
Texas (962)
United States (24479)
Utah (191)
Virginia (153)
Washington D.C. (67)
Washington State (575)
West Virginia (3)
Wisconsin (57)
719,280 Results for "vital therapies inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Lone Star Bio
Vitality Blueprint Unveils Performance Bloodwork Platform
Vitality Blueprint, Inc., a leader in human performance science, is proud to introduce its groundbreaking Performance Bloodwork Platform.
April 1, 2024
·
3 min read
Press Releases
Ostro Partners with Desmoid Tumor Research Foundation to Enhance Patient Access to Vital Resources
January 27, 2025
·
2 min read
Gene therapy
Vertex Abandons AAV as Gene Therapy Space Weathers Difficulties
The cell and gene therapy space in recent months has hit several speedbumps, including layoffs, dropped drugs and discontinued partnerships.
May 5, 2025
·
2 min read
·
Tristan Manalac
Business
Lucas Vitale Joins Orthofix as Chief People and Business Operations Officer
Orthofix Medical Inc., a leading global spine and orthopedics company, announced that Lucas Vitale has joined the company in the newly created role of Chief People and Business Operations Officer.
March 18, 2024
·
5 min read
Press Releases
Johnson & Johnson Closes Landmark Intra-Cellular Therapies, Inc. Acquisition to Solidify Neuroscience Leadership
April 2, 2025
·
10 min read
Business
Mindset Medical, Inc Raises Funds to Continue Development and Clinical Trials for Informed Vital Core
Mindset Medical, Inc., a software as a medical device company, has announced the closing of a Series A financing.
June 6, 2024
·
3 min read
Business
Former QuidelOrtho CEO Douglas Bryant Joins Board of Directors of Vital Biosciences
Vital Biosciences today announced that Mr. Douglas Bryant has joined the company’s Board of Directors.
April 9, 2024
·
3 min read
Policy
FDA’s Marks: Global Regulatory Convergence Vital to Cell & Gene Therapy Oversight
At a Thursday ASGCT 2024 session, CBER Director Peter Marks made the case for a better, “more convergent” global framework on cell and gene therapies, especially for rare diseases.
May 9, 2024
·
3 min read
·
Greg Slabodkin
Press Releases
SpineX Inc. Announces Significant Improvement in Urinary Bladder Function in Paralyzed Individuals with SCONE™ Therapy
April 16, 2025
·
2 min read
Press Releases
Vivos Inc. Reports Continued Progress in India Human Clinical Trial for RadioGel® Precision Radionuclide Therapy™
April 16, 2025
·
5 min read
1 of 71,928
Next
